Kerin Adelson, M.D., is a practicing breast cancer oncologist and serves as chief quality officer and deputy chief medical officer at Smilow Cancer Hospital and Yale Cancer Center within the Yale New Haven Health System. As a key member of the executive leadership team, she oversees clinical innovation and care redesign with a focus on patient-centered, high-value care. With expertise in value-based care, she oversees medical home models, multidisciplinary centers of excellence, and direct-to-employer strategy for the Oncology service line. She is an Associate Professor, Division of Hematology/Oncology, Yale University School of Medicine.